Approval · Notice of Compliance 11559 · 2010
TRELSTAR: Notice of Compliance 11559
Issued June 25, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11559
- Date
- June 25, 2010
- Company
- Watson Pharma Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Luteinizing hormone-releasing hormone (LHRH) analog
Products in this notice
Medicinal ingredients
- TRIPTORELIN PAMOATE 3.75 MG per VIAL
- TRIPTORELIN PAMOATE 11.25 MG per VIAL